• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服头孢菌素类药物的药代动力学——综述

The pharmacokinetics of the oral cephalosporins--a review.

作者信息

Wise R

机构信息

Department of Medical Microbiology, Dudley Road Hospital, Birmingham, UK.

出版信息

J Antimicrob Chemother. 1990 Dec;26 Suppl E:13-20. doi: 10.1093/jac/26.suppl_e.13.

DOI:10.1093/jac/26.suppl_e.13
PMID:2292525
Abstract

The pharmacokinetics of the older and more recent oral cephalosporins are reviewed. With the exception of cefadroxil the older agents (cephalexin, cephradine and cefaclor) have serum elimination half-lives of less than or equal to 1 h and hence have to be administered three to four times daily. The urinary recovery of these agents is high (greater than 80% of oral dose) with the exception of cefaclor (54%). Cefaclor is also chemically unstable. The newer agents can be divided into those that are prodrugs (cefpodoxime proxetil and cefuroxime axetil) and compounds that are absorbed as such (cefixime, cefprozil and ceftibuten). They all have half-lives greater than 1.25 h and can be given once or twice daily. The penetration of these agents into an inflammatory exudate was studied and found to be cefixime 132%, ceftibuten 113%, cefpodoxime 104%, cefuroxime 92% and cefprozil 79% of the serum concentration. The penetration of cefpodoxime and cefixime into the respiratory tract was also studied; the mean percentage bronchial mucosal penetration was 52% for the former and 38% for cefixime. The urinary recovery of these newer agents (with the exception of ceftibuten) tends to be less than that of the earlier agents. There was a relationship between the serum elimination half-life of these agents and the degree of tissue penetration, those agents with longer half-lives penetrating to a greater extent.

摘要

本文综述了早期和近期口服头孢菌素的药代动力学。除头孢羟氨苄外,早期的药物(头孢氨苄、头孢拉定和头孢克洛)血清消除半衰期小于或等于1小时,因此必须每日给药三至四次。除头孢克洛(54%)外,这些药物的尿回收率很高(大于口服剂量的80%)。头孢克洛化学性质也不稳定。较新的药物可分为前体药物(头孢泊肟酯和头孢呋辛酯)和直接吸收的化合物(头孢克肟、头孢丙烯和头孢布烯)。它们的半衰期均大于1.25小时,可每日给药一次或两次。研究了这些药物在炎性渗出液中的渗透情况,发现头孢克肟为血清浓度的132%,头孢布烯为113%,头孢泊肟为104%,头孢呋辛为92%,头孢丙烯为79%。还研究了头孢泊肟和头孢克肟在呼吸道中的渗透情况;前者支气管黏膜平均渗透百分比为52%,头孢克肟为38%。这些较新药物(除头孢布烯外)尿液回收率往往低于早期药物。这些药物的血清消除半衰期与组织渗透程度之间存在关联,半衰期较长的药物渗透程度更高。

相似文献

1
The pharmacokinetics of the oral cephalosporins--a review.口服头孢菌素类药物的药代动力学——综述
J Antimicrob Chemother. 1990 Dec;26 Suppl E:13-20. doi: 10.1093/jac/26.suppl_e.13.
2
Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers.健康志愿者口服头孢布烯、头孢克肟、头孢克洛和头孢呋辛酯的比较药代动力学。
Pharmacotherapy. 1997 Jan-Feb;17(1):121-5.
3
Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil.头孢泊肟与头孢克肟、头孢地尼、头孢他美、头孢布烯、氯碳头孢、头孢丙烯、BAY 3522、头孢呋辛、头孢克洛和头孢羟氨苄的抗菌活性比较。
Infection. 1991 Sep-Oct;19(5):353-62. doi: 10.1007/BF01645369.
4
Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.头孢丙烯、头孢泊肟酯、氯碳头孢、头孢克肟和头孢布烯的比较。
Ann Pharmacother. 1996 Mar;30(3):258-68. doi: 10.1177/106002809603000310.
5
Oral cephalosporins.
Acta Clin Belg. 1992;47(6):377-86. doi: 10.1080/17843286.1992.11718259.
6
Clinical pharmacokinetics of five oral cephalosporins in calves.五种口服头孢菌素在犊牛体内的临床药代动力学
Res Vet Sci. 1987 Sep;43(2):166-72.
7
[Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins].[头孢克肟在志愿者体内的药代动力学及与新型酯前药头孢菌素的文献比较]
Infection. 1990;18 Suppl 3:S150-4. doi: 10.1007/BF01644636.
8
Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides.头孢丙烯与13种口服头孢菌素及3种大环内酯类药物的抗菌活性比较。
Antimicrob Agents Chemother. 1995 Feb;39(2):533-8. doi: 10.1128/AAC.39.2.533.
9
Ceftibuten and bactericidal kinetics. Comparative in vitro activity against Enterobacteriaceae producing extended spectrum beta-lactamases.头孢布烯与杀菌动力学。对产超广谱β-内酰胺酶肠杆菌科细菌的体外活性比较
Diagn Microbiol Infect Dis. 1991 Jan-Feb;14(1):89-92. doi: 10.1016/0732-8893(91)90095-w.
10
RU 29 246, the active compound of the cephalosporin prodrug-ester HR 916. III. Pharmacokinetic properties and antibacterial activity in vivo.RU 29 246,头孢菌素前药酯HR 916的活性化合物。III. 体内药代动力学特性和抗菌活性
J Antibiot (Tokyo). 1992 Jun;45(6):922-31. doi: 10.7164/antibiotics.45.922.

引用本文的文献

1
Synthetic Approaches, Properties, and Applications of Acylals in Preparative and Medicinal Chemistry.酰基试剂在制备和药物化学中的合成方法、性质和应用
Molecules. 2024 Sep 19;29(18):4451. doi: 10.3390/molecules29184451.
2
Treatment failure definitions for non-purulent skin and soft tissue infections: a systematic review.非化脓性皮肤及软组织感染的治疗失败定义:系统评价。
Infection. 2020 Feb;48(1):75-83. doi: 10.1007/s15010-019-01347-w. Epub 2019 Aug 5.
3
Influence of Food on Paediatric Gastrointestinal Drug Absorption Following Oral Administration: A Review.
食物对小儿口服胃肠道药物吸收的影响:综述
Children (Basel). 2015 Jun 9;2(2):244-71. doi: 10.3390/children2020244.
4
Detection of favorable oral cephalosporin-clavulanate interactions by in vitro disk approximation susceptibility testing of extended-spectrum-Beta-lactamase-producing members of the enterobacteriaceae.通过对产超广谱β-内酰胺酶的肠杆菌科成员进行体外磁盘近似药敏试验来检测有利的口腔头孢菌素-克拉维酸相互作用。
J Clin Microbiol. 2012 Mar;50(3):1023-6. doi: 10.1128/JCM.06248-11. Epub 2011 Dec 14.
5
Comparison of ceftibuten vs. amoxicillin/clavulanic acid as antibiotic prophylaxis in cholecystectomy and/or biliary tract surgery.头孢布烯与阿莫西林/克拉维酸在胆囊切除术和/或胆道手术中作为抗生素预防性用药的比较。
J Gastrointest Surg. 2000 Nov-Dec;4(6):606-10. doi: 10.1016/s1091-255x(00)80109-2.
6
Clinical and economic considerations in the use of third-generation oral cephalosporins.使用第三代口服头孢菌素的临床和经济考量
Pharmacoeconomics. 1995 May;7(5):416-27. doi: 10.2165/00019053-199507050-00006.
7
In vitro activities of oral beta-lactams at concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance.口服β-内酰胺类药物在人体所能达到的浓度下对青霉素敏感和耐药肺炎链球菌的体外活性及产生耐药性的可能性。
Antimicrob Agents Chemother. 1998 Aug;42(8):1973-9. doi: 10.1128/AAC.42.8.1973.
8
A study to determine the pharmacokinetics and inflammatory fluid penetration of two doses of a solid formulation of the hexetil prodrug of a trinem, sanfetrinem (GV 104326).一项旨在确定三嗪类化合物sanfetrinem(GV 104326)的己酯前药两种剂量固体剂型的药代动力学及炎性液体渗透情况的研究。
Antimicrob Agents Chemother. 1997 Aug;41(8):1761-4. doi: 10.1128/AAC.41.8.1761.
9
Pharmacokinetics of cefetamet in plasma and skin blister fluid.头孢他美在血浆和皮肤水疱液中的药代动力学。
Antimicrob Agents Chemother. 1996 Jan;40(1):102-4. doi: 10.1128/AAC.40.1.102.
10
Shedding of Clostridium difficile, fecal beta-lactamase activity, and gastrointestinal symptoms in 51 volunteers treated with oral cefixime.51名口服头孢克肟志愿者的艰难梭菌脱落、粪便β-内酰胺酶活性及胃肠道症状
Antimicrob Agents Chemother. 1993 Jul;37(7):1432-5. doi: 10.1128/AAC.37.7.1432.